Integrative genomic and network analysis identified novel genes associated with the development of advanced cervical squamous cell carcinoma.

[1]  S. Xiao,et al.  Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition , 2016, Hepatology.

[2]  T. Hofmann,et al.  The DNA damage-induced cell death response: a roadmap to kill cancer cells , 2016, Cellular and Molecular Life Sciences.

[3]  M. P. Kirpichnikov,et al.  PARP1 Inhibitors: antitumor drug design , 2015, Acta naturae.

[4]  Matjaz Perc,et al.  Network Topologies Decoding Cervical Cancer , 2015, PloS one.

[5]  T. Wright,et al.  Amplification of the 3q chromosomal region as a specific marker in cervical cancer. , 2015, American journal of obstetrics and gynecology.

[6]  Jisoo Park,et al.  Association of p21‐activated kinase‐1 activity with aggressive tumor behavior and poor prognosis of head and neck cancer , 2015, Head & neck.

[7]  J. Nissink,et al.  Drugging ATR: progress in the development of specific inhibitors for the treatment of cancer. , 2015, Future medicinal chemistry.

[8]  V. Sherwood,et al.  WNT Signaling: an Emerging Mediator of Cancer Cell Metabolism? , 2014, Molecular and Cellular Biology.

[9]  Doron Lancet,et al.  MalaCards: A Comprehensive Automatically‐Mined Database of Human Diseases , 2014, Current protocols in bioinformatics.

[10]  R. Dayam,et al.  A review on PARP1 inhibitors: Pharmacophore modeling, virtual and biological screening studies to identify novel PARP1 inhibitors. , 2014, Current Topics in Medicinal Chemistry.

[11]  R. Xie,et al.  Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer , 2014, Diagnostic Pathology.

[12]  E. Petricoin,et al.  Integrated Genomic and Epigenomic Analysis of Breast Cancer Brain Metastasis , 2014, PloS one.

[13]  Zhiwen Xu,et al.  Construction and analysis of regulatory genetic networks in cervical cancer based on involved microRNAs, target genes, transcription factors and host genes , 2014, Oncology letters.

[14]  P. Mondal,et al.  Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes , 2013, PloS one.

[15]  Andrey Morgun,et al.  Gene network reconstruction reveals cell cycle and antiviral genes as major drivers of cervical cancer , 2013, Nature Communications.

[16]  Martin Koch,et al.  Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer , 2013, Journal of Cancer Research and Clinical Oncology.

[17]  C. Meijer,et al.  Focal aberrations indicate EYA2 and hsa‐miR‐375 as oncogene and tumor suppressor in cervical carcinogenesis , 2013, Genes, chromosomes & cancer.

[18]  A. Chinnaiyan,et al.  Dual roles of PARP-1 promote cancer growth and progression. , 2012, Cancer discovery.

[19]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[20]  E. Sala,et al.  The revised FIGO staging system for uterine malignancies: implications for MR imaging. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  S. Roychoudhury,et al.  Inactivation of SLIT2-ROBO1/2 Pathway in Premalignant Lesions of Uterine Cervix: Clinical and Prognostic Significances , 2012, PloS one.

[22]  Chi V Dang,et al.  Links between metabolism and cancer. , 2012, Genes & development.

[23]  L. Orozco,et al.  Amplified Genes May Be Overexpressed, Unchanged, or Downregulated in Cervical Cancer Cell Lines , 2012, PloS one.

[24]  D. Haidopoulos,et al.  Role of Chromosome 3q26 Gain in Predicting Progression of Cervical Dysplasia , 2012, International Journal of Gynecologic Cancer.

[25]  Ratnesh K Singh,et al.  Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. , 2011, Gynecologic oncology.

[26]  Kenneth R. Shroyer,et al.  Biomarkers of Cervical Dysplasia and Carcinoma , 2011, Journal of oncology.

[27]  P. Luhn,et al.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. , 2011, Future microbiology.

[28]  V. Murty,et al.  Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis. , 2010, Future oncology.

[29]  C. Perou,et al.  Allele-specific copy number analysis of tumors , 2010, Proceedings of the National Academy of Sciences.

[30]  Tsviya Olender,et al.  GeneCards Version 3: the human gene integrator , 2010, Database J. Biol. Databases Curation.

[31]  Bernardo Celda,et al.  New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile , 2010, Modern Pathology.

[32]  A. Shlien,et al.  Copy number variations and cancer , 2009, Genome Medicine.

[33]  Wessel N van Wieringen,et al.  Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer , 2008, Genes, chromosomes & cancer.

[34]  X. Castellsagué.  Natural history and epidemiology of HPV infection and cervical cancer. , 2008, Gynecologic oncology.

[35]  M. Mansukhani,et al.  Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression , 2008, Genes, chromosomes & cancer.

[36]  H. Jung,et al.  Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer , 2007, International Journal of Gynecologic Cancer.

[37]  Ratnesh K Singh,et al.  Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene , 2007, Human Genetics.

[38]  W. Ahn,et al.  Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis , 2006, International Journal of Gynecologic Cancer.

[39]  K. Basso,et al.  Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genes , 2007, Genes, chromosomes & cancer.

[40]  Ekaterina S Jordanova,et al.  Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer , 2007, BMC Genomics.

[41]  David I. Smith,et al.  Genome‐wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray , 2006, International journal of cancer.

[42]  N. Sampas,et al.  Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Symington,et al.  EXO1-A multi-tasking eukaryotic nuclease. , 2004, DNA repair.

[44]  F. Giostra,et al.  Methods and Results , 2014 .

[45]  N. Bhattacharyya,et al.  Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population , 2001, International journal of cancer.

[46]  R. Richart,et al.  Alterations in chromosomes and DNA content in gynecologic neoplasms. , 1969, American journal of obstetrics and gynecology.

[47]  D. Hughes,et al.  Chromosomal anomalies in dysplasia, carcinoma-in-situ, and carcinoma of cervix uteri. , 1965, Lancet.

[48]  M. von Knebel Doeberitz,et al.  Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - a systematic review and meta-analysis. , 2014, European journal of cancer.

[49]  K. Kaarthigeyan.  Cervical cancer in India and HPV vaccination , 2012, Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology.

[50]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[51]  T. Barrette,et al.  ONCOMINE: a cancer microarray database and integrated data-mining platform. , 2004, Neoplasia.

[52]  RESEARCH ARTICLE Open Access Identification and validation of genes involved in cervical tumourigenesis , 2022 .